 Effects long-term verapamil therapy serum lipids metabolic parameters Calcium antagonists management hypertension decade long-term metabolic effects impact calcium antagonist verapamil serum lipids metabolic parameters hypertensive patients verapamil monotherapy years mean treatment period years total cholesterol triglyceride levels different baseline mean high-density lipoprotein cholesterol value mmol/L initiation treatment mmol/L years Other important biochemical parameters serum glucose potassium uric acid levels verapamil therapy serious side effects adverse cardiovascular events verapamil therapy study likely agent useful long-term management essential hypertension